The Heated Dispute Between CME and CFTC Over On-Chain Perpetual Futures

The conflict between the CME Group and the US Commodity Futures Trading Commission (CFTC) has escalated into a full-blown dispute, with the CME suing the CFTC over its decision to allow the listing of blockchain-based perpetual future products. The CME claims that these products, which enable users to speculate on asset prices with leverage and no expiration date, are being mislabeled and that the CFTC is misapplying the law. The regulator's move has been seen as a significant shift in the US approach to the rapidly growing market, with non-US perpetual futures volume reportedly reaching $60 trillion in the last year. The CME argues that the CFTC's sudden embrace of perpetual futures did not consider the potential consequences and that these products are harmful to its long-dated futures products. The lawsuit has sparked a heated debate, with some voicing frustration and outrage at the CME's stance. The CFTC's chairman, Mike Selig, has defended the regulator's decision, stating that the CME's actions are 'wholly inappropriate'. The dispute has significant implications for the US derivatives market and the regulation of on-chain perpetual futures. The CME's influence over commodities and its role in shaping US regulatory policy have contributed to the tension between the two entities. The outcome of the lawsuit is likely to have far-reaching consequences for the US approach to the rapidly evolving market.